Search Results - "Bettina, Heschl"
-
1
COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry
Published in PloS one (27-07-2021)“…Background The COVID-19 pandemic challenges neurologists in counselling patients with multiple sclerosis (pwMS) regarding their risk by SARS-CoV-2 and in…”
Get full text
Journal Article -
2
Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study
Published in Multiple sclerosis (01-12-2021)“…Background: Knowledge on immunity after SARS-CoV-2 infection in patients with multiple sclerosis (pwMS) and the impact of disease-modifying treatment (DMT) is…”
Get full text
Journal Article -
3
Low-frequency MR elastography reveals altered deep gray matter viscoelasticity in multiple sclerosis
Published in NeuroImage clinical (01-01-2024)“…[Display omitted] •Low-frequency MRE reveals altered deep gray matter viscoelasticity in MS patients.•Thalamic viscoelasticity is changed in MS independent of…”
Get full text
Journal Article -
4
Long‐term outcome after COVID‐19 infection in multiple sclerosis: A nation‐wide multicenter matched‐control study
Published in European journal of neurology (01-10-2022)“…Background and purpose Long‐term outcome after COVID‐19 in patients with multiple sclerosis (pwMS) has scarcely been studied, and controlled data are lacking…”
Get full text
Journal Article -
5
Individuelle MS-Therapie: Der Weg zur richtigen Therapie – manchmal einfach, manchmal schwer
Published in Psychopraxis neuropraxis (01-10-2024)“…Zusammenfassung Zur Behandlung der multiplen Sklerose zeigte sich in den letzten Jahren ein stetiger Zuwachs neuer Therapieoptionen und es steht derzeit eine…”
Get full text
Journal Article -
6
Anti-CD20 treatment and neutrophil function in central nervous system demyelinating diseases
Published in Journal of neuroimmunology (15-08-2023)“…A contribution of neutrophil granulocytes to the pathogenesis of multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) is recognized…”
Get full text
Journal Article -
7
Evaluation of the T25FW in minimally disabled people with multiple sclerosis
Published in Journal of the neurological sciences (15-07-2024)“…Walking impairment is one of the most prevalent symptoms in people with multiple sclerosis (pwMS). In this study, we aimed to explore the usefulness of a…”
Get full text
Journal Article -
8
Evaluation of a self-administered iPad®-based processing speed assessment for people with multiple sclerosis in a clinical routine setting
Published in Journal of neurology (01-06-2024)“…Background Limited resources often hinder regular cognitive assessment of people with multiple sclerosis (pwMS) in standard clinical care. A self-administered…”
Get full text
Journal Article -
9
Actual and Imagined Music-Cued Gait Training in People with Multiple Sclerosis: A Double-Blind Randomized Parallel Multicenter Trial
Published in Neurorehabilitation and neural repair (01-08-2024)“…Background Actual and imagined cued gait trainings have not been compared in people with multiple sclerosis (MS). Objective To analyze the effects of cued…”
Get full text
Journal Article -
10
Psychological factors and brain magnetic resonance imaging metrics associated with fatigue in persons with multiple sclerosis
Published in Journal of the neurological sciences (15-11-2023)“…Besides demographics and clinical factors, psychological variables and brain-tissue changes have been associated with fatigue in persons with multiple…”
Get full text
Journal Article -
11
Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy
Published in Microbes and infection (01-05-2023)“…B-cell depleting therapies result in diminished humoral immunity following vaccination against COVID-19, but our understanding on the impact on cellular immune…”
Get full text
Journal Article -
12
Impact of vaccination on COVID‐19 outcome in multiple sclerosis
Published in European journal of neurology (01-11-2022)“…Background and purpose COVID‐19 continues to challenge neurologists in counseling persons with multiple sclerosis (pwMS) regarding disease‐modifying treatment…”
Get full text
Journal Article